Picard Medical Q1 FY26 net loss widens 37% to $7.62 million; revenue rises 85% to $1.15 million

Picard Medical, Inc.

Picard Medical, Inc.

PMI

0.00
  • Picard Medical posted a net loss of USD 7.62 million, widening 37% from a year earlier.
  • Revenue rose 85% to USD 1.15 million, driven by a USD 0.6 million increase in U.S. sales, partly offset by a USD 0.1 million decline in Europe.
  • Operating loss widened 39% to USD 4.51 million as research and development expense more than doubled to USD 1.9 million.
  • Selling, general and administrative costs climbed 39% to USD 2.89 million on USD 0.8 million higher professional and legal expenses.
  • NYSE American issued a noncompliance notice tied to USD 3.8 million stockholders’ equity at Dec. 31, 2025, requiring a compliance plan by June 7, 2026, with a cure deadline of Nov. 8, 2027.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Picard Medical Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-26-017342), on May 15, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.